Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Apr 30;27(9):2861.
doi: 10.3390/molecules27092861.

Phytochemical Profile of Antibacterial Agents from Red Betel Leaf (Piper crocatum Ruiz and Pav) against Bacteria in Dental Caries

Affiliations
Review

Phytochemical Profile of Antibacterial Agents from Red Betel Leaf (Piper crocatum Ruiz and Pav) against Bacteria in Dental Caries

Leny Heliawati et al. Molecules. .

Abstract

Based on data from The Global Burden of Disease Study in 2016, dental and oral health problems, especially dental caries, are a disease experienced by almost half of the world's population (3.58 billion people). One of the main causes of dental caries is the pathogenesis of Streptococcus mutans. Prevention can be achieved by controlling S. mutans using an antibacterial agent. The most commonly used antibacterial for the treatment of dental caries is chlorhexidine. However, long-term use of chlorhexidine has been reported to cause resistance and some side effects. Therefore, the discovery of a natural antibacterial agent is an urgent need. A natural antibacterial agent that can be used are herbal medicines derived from medicinal plants. Piper crocatum Ruiz and Pav has the potential to be used as a natural antibacterial agent for treating dental and oral health problems. Several studies reported that the leaves of P. crocatum Ruiz and Pav contain secondary metabolites such as essential oils, flavonoids, alkaloids, terpenoids, tannins, and phenolic compounds that are active against S. mutans. This review summarizes some information about P. crocatum Ruiz and Pav, various isolation methods, bioactivity, S. mutans bacteria that cause dental caries, biofilm formation mechanism, antibacterial properties, and the antibacterial mechanism of secondary metabolites in P. crocatum Ruiz and Pav.

Keywords: Piper crocatum Ruiz and Pav; Streptococcus mutans; antibacterial; phytochemical profiling; red betel leaf.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
(A) Co-aggregation between S. mutans and filaments in developing dental biofilm; (B) typical corncob formation [30].
Figure 2
Figure 2
Contribution of S. mutans in the process of biofilm formation [39].
Figure 3
Figure 3
Pathway of inhibition of bacteria by antibacterial agents [73].
Figure 4
Figure 4
Catalytic reaction on the MurA enzyme [106].
Figure 5
Figure 5
Compounds obtained from the methanol extract of red betel leaf. (1) (8R)-8-(4-hydroxy-3,5-dimethoxy)-propane-8-ol-4-O-β-D-glucopyranoside; (2) 4-Allyl-2,6-dimethoxy-3-hydroxy-1-D-glucopyranoside; (3) 3-[(1E)-3-hydroxy-1-propen-1-yl]-2,5-dimethoxyphenyl-D-glucopyranoside; (4) Cimidahurinin; (5) Erigeside II; (6) Syringe; (7) β-phenylethyl-β-D-glucoside; (8) Methylsalicylate-2-O-β-D-glucopyranoside; (9) Icariside D1; (10) 4-Hydroxybenzoic acid-D-glucosylester; (11) Benzyl-β-D-glucoside; (12) Phenylmethyl-6-O-α-L-arabinofuranosyl-β-D-glucopyranoside; (13) Hydroxytyrosol-1glucopyranoside (14) Gentisic acid; (15) Catechaldehyde; (16) (S)-Menthiafolic acid; (17) Ioliolide; (18) 5β,6β-dihydroxy-3α-(β-D-glucopyranosyloxy)-7E-Megastigmen-9-one; (19) (3E)-4-[(1S,2S,4S)-4-(β-D-glucopyranosyloxy)-1,2-dihydroxy-2,6,6-tri-methylcyclohexyl]3-buten-2-one; (20) (6S,9S)-roseoside; (21) Cuneataside E (22) N-trans-feruloyltyramine-4′-O-β-D-glucopyranoside; (23) Syringaresinol-β-D-glucoside; and (24) Vitexin 2″-O-rhamnoside.
Figure 5
Figure 5
Compounds obtained from the methanol extract of red betel leaf. (1) (8R)-8-(4-hydroxy-3,5-dimethoxy)-propane-8-ol-4-O-β-D-glucopyranoside; (2) 4-Allyl-2,6-dimethoxy-3-hydroxy-1-D-glucopyranoside; (3) 3-[(1E)-3-hydroxy-1-propen-1-yl]-2,5-dimethoxyphenyl-D-glucopyranoside; (4) Cimidahurinin; (5) Erigeside II; (6) Syringe; (7) β-phenylethyl-β-D-glucoside; (8) Methylsalicylate-2-O-β-D-glucopyranoside; (9) Icariside D1; (10) 4-Hydroxybenzoic acid-D-glucosylester; (11) Benzyl-β-D-glucoside; (12) Phenylmethyl-6-O-α-L-arabinofuranosyl-β-D-glucopyranoside; (13) Hydroxytyrosol-1glucopyranoside (14) Gentisic acid; (15) Catechaldehyde; (16) (S)-Menthiafolic acid; (17) Ioliolide; (18) 5β,6β-dihydroxy-3α-(β-D-glucopyranosyloxy)-7E-Megastigmen-9-one; (19) (3E)-4-[(1S,2S,4S)-4-(β-D-glucopyranosyloxy)-1,2-dihydroxy-2,6,6-tri-methylcyclohexyl]3-buten-2-one; (20) (6S,9S)-roseoside; (21) Cuneataside E (22) N-trans-feruloyltyramine-4′-O-β-D-glucopyranoside; (23) Syringaresinol-β-D-glucoside; and (24) Vitexin 2″-O-rhamnoside.
Figure 6
Figure 6
Compounds obtained from the methanolic extract of red betel leaf (P. crocatum Ruiz and Pav). (25) β-sitosterol and (26) 2-(5′,6′-dimethoxy-3′,4′-methylenedioxyphenyl)-6-(3″,4″,5-trimethoxyphenyl)-dioxabiclo [3,3,0] octane.
Figure 7
Figure 7
Compounds obtained from the methanolic extract of red betel leaf (P. crocatum Ruiz and Pav). (27) Crocatin A; (28) Crocatin B; (29) Pachypodol [4′,5-dihydroxy-3,3′,7-trimethoxyflavone]; and (30) 1-Triacontanol.
Figure 8
Figure 8
Compounds obtained from the methanolic extract of red betel leaf. (31) Pipcroside A; (32) Pipcroside B; (33) Pipcroside C; and (34) Bicyclo [3.2.1] octanoid neolignans.
Figure 9
Figure 9
Structure of compounds of isolated red betel leaf oil. (35) Camphene and (36) Myrcene [13].

Similar articles

Cited by

References

    1. Kuang X., Chen V., Xu X. Novel Approaches to the Control of Oral Microbial Biofilms. Biomed. Res. Int. 2018;2018:6498932. doi: 10.1155/2018/6498932. - DOI - PMC - PubMed
    1. Jiao Y., Tay F.R., Niu L.-N., Chen J. Hua Advancing Antimicrobial Strategies for Managing Oral Biofilm Infections. Int. J. Oral Sci. 2019;11:28. doi: 10.1038/s41368-019-0062-1. - DOI - PMC - PubMed
    1. Verma D., Garg P.K., Dubey A.K. Insights into the Human Oral Microbiome. Arch. Microbiol. 2018;200:525–540. doi: 10.1007/s00203-018-1505-3. - DOI - PubMed
    1. Peres M.A., Macpherson L.M.D., Weyant R.J., Daly B., Venturelli R., Mathur M.R., Listl S., Celeste R.K., Guarnizo-Herreño C.C., Kearns C., et al. Oral Diseases: A Global Public Health Challenge. Lancet. 2019;394:249–260. doi: 10.1016/S0140-6736(19)31146-8. - DOI - PubMed
    1. Irani S. Oral Health and Related Factors: An Update. J. Int. Oral Health. 2016;8:1140–1144. doi: 10.2047/Jioh-08-12-19. - DOI